Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return

[1]  U. B. Olsen,et al.  N″-cyano-N-4-pyridyl-N′-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): A new, potent vasodilator , 1980, Experientia.

[2]  Y. Imai,et al.  Role of the Peripheral Vasculature in Changes in Venous Return Caused by Isoproterenol, Norepinephrine, and Methoxamine in Anesthetized Dogs , 1978, Circulation Research.

[3]  L. Opie.  Calcium channel antagonists part IV: Side effects and contraindications drug interactions and combinations , 1988, Cardiovascular Drugs and Therapy.

[4]  N. Taira,et al.  Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery , 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  T. Yanagisawa,et al.  Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog , 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  T. Yanagisawa,et al.  The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle , 1988, British journal of pharmacology.

[7]  N. Taira,et al.  Is the Cardiovascular Profile of BRL 34915 Characteristic of Potassium Channel Activators? , 1988, Journal of Cardiovascular Pharmacology.

[8]  C. Pally,et al.  Similarities in the Mechanism of Action of Two New Vasodilator Drugs: Pinacidil and BRL 34915 , 1988, Journal of cardiovascular pharmacology.

[9]  N. Taira,et al.  Pinacidil increases the background potassium current in single ventricular cells. , 1987, European journal of pharmacology.

[10]  Kenzo Takahashi,et al.  Effect of DHP‐218, a Novel Dihydropyridine Phosphonate, on Atrioventricular Nodal Conductivity Compared with Its Vascular Effect in Dogs , 1987, Journal of Cardiovascular Pharmacology.

[11]  A. Weston,et al.  New class of antihypertensive acts by opening K+ channels , 1987 .

[12]  N. Taira,et al.  Differences in cardiovascular profile among calcium antagonists. , 1987, The American journal of cardiology.

[13]  N. Taira.  Similarity and Dissimilarity in the Mode and Mechanism of Action Between Nicorandil and Classical Nitrates: An Overview , 1987, Journal of cardiovascular pharmacology.

[14]  T. Aizawa,et al.  Effects of Nicorandil on Coronary Circulation in Patients with Ischemic Heart Disease: Comparison with Nitroglycerin , 1987, Journal of Cardiovascular Pharmacology.

[15]  A. Weston,et al.  The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels , 1986, British journal of pharmacology.

[16]  J. Clapham,et al.  BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. , 1986, Journal of cardiovascular pharmacology.

[17]  S. Holzmann.  Cyclic GMP as Possible Mediator of Coronary Arterial Relaxation by Nicorandil (SG‐75) , 1983, Journal of cardiovascular pharmacology.

[18]  T. Itoh,et al.  Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. , 1981, The Journal of pharmacology and experimental therapeutics.

[19]  柳澤 輝行.  Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog : increase in potassium conductance , 1980 .

[20]  Y. Imai,et al.  Differential effects of nitroglycerin, trimetazidine, verapamil and SK&F 24260 on venous return as revealed by the open-loop method in the dog. , 1980, Japanese journal of pharmacology.

[21]  Y. Imai,et al.  PHARMACOLOGICAL PROFILE OF A NEW CORONARY VASODILATOR DRUG, 2‐NICOTINAMIDOETHYL NITRATE (SG‐75) , 1979, Clinical and experimental pharmacology & physiology.

[22]  T. Yanagisawa,et al.  Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75). , 1979, Japanese journal of pharmacology.

[23]  E. Arrigoni-Martelli,et al.  SYNTHESIS AND HYPOTENSIVE ACTIVITY OF N-ALKYL-N′′-CYANO-N′-PYRIDYLGUANIDINES , 1978 .

[24]  Y. Imai,et al.  Role of the Peripheral Vasculature in Changes in Venous Return Caused by Isoproterenol, Norepinephrine, and Methoxamine in Anesthetized Dogs , 1978, Circulation research.

[25]  E. Arrigoni-Martelli,et al.  Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines. , 1978, Journal of medicinal chemistry.

[26]  Y. Uchida,et al.  Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation. , 1978, Japanese heart journal.

[27]  Y. Imai,et al.  Cardiohemodynamic effects of SK&F 24260, D 600, diltiazem, dilazep, and trimetazidine in the dog. , 1977, Japanese heart journal.

[28]  N. Taira,et al.  Cardiohemodynamic effects of nitroglycerin and several vasodilators. , 1974, Japanese heart journal.

[29]  W. Lochner,et al.  Effects of nitroglycerin, dipyridamole, carbocromen, xanthinol nicotinate, and butallylonal on venous return. , 1972, Arzneimittel-Forschung.

[30]  J. Ross,et al.  ALPHA AND BETA ADRENERGIC RECEPTOR MECHANISMS IN THE SYSTEMIC VENOUS BED. , 1964, The Journal of pharmacology and experimental therapeutics.

[31]  W. D. Halliburton,et al.  Handbook of Physiology , 1870, Edinburgh Medical Journal.